Chronic kidney disease (CKD)
- Slow progression + reduce CV risk
- Control BP; ACEi/ARB if albuminuric
- SGLT2 inhibitor for many CKD patients
- Finerenone in selected T2DM + albuminuria
- Avoid nephrotoxins; dose drugs to kidney function
- Treat acidosis, anemia, K+ and CKD-MBD
- Refer as risk/eGFR/complications increase
Use at a glance
- Slow progression + reduce CV risk
Practical pearls
- SGLT2 inhibitor for many CKD patients
- Treat acidosis, anemia, K+ and CKD-MBD
Choosing treatment
- Control BP; ACEi/ARB if albuminuric
- Finerenone in selected T2DM + albuminuria
Safety / pitfalls
- Avoid nephrotoxins; dose drugs to kidney function
- Refer as risk/eGFR/complications increase
Self-check
- Which class benefits many CKD patients?
SGLT2 inhibitors. - What should guide CKD drug dosing?
Kidney function.
Drugs used for this (3)
All clinical uses · Open Chronic kidney disease (CKD) in the interactive console ↗